Key Takeaways
- Shares of Oracle climbed 2% to reach $157.13, extending momentum from Thursday’s 5.7% surge linked to Federal Reserve commentary
- Morgan Stanley elevated its price objective to $210 from $207, pointing to enhanced margins in GPU-as-a-Service operations
- Bernstein maintained its Outperform stance, indicating Oracle could be approaching the conclusion of its capital-raising phase
- Jefferies preserved its Buy recommendation while adjusting its target downward to $290 from $320, emphasizing OCI revenue expansion and margin performance as critical indicators
- The company is scheduled to announce Q1 fiscal 2027 earnings on September 10, 2026, following the closing bell
Shares of Oracle experienced a 2% uptick during morning hours, reaching $157.13, as Wall Street firms issued updated research notes and market participants prepared for the company’s upcoming quarterly report.
The gain extends Thursday’s robust 5.7% advance, which was sparked by Federal Reserve Governor Christopher Waller’s comments favoring stable interest rates pending additional inflation information. This development carries particular weight for Oracle, given the company’s substantial debt load accumulated to finance its artificial intelligence data center expansion.
Morgan Stanley increased its price objective to $210 from $207 while maintaining an Equalweight stance. The adjustment reflects an enhanced margin forecast for Oracle’s GPU-as-a-Service operations. The firm applied approximately 19 times its calendar 2028 non-GAAP earnings per share projection of $10.98 in its valuation model.
The shares remain approximately 20% lower year-to-date, trading below historical valuation benchmarks. Oracle’s PEG ratio stands at 0.77, with InvestingPro identifying the equity as undervalued when measured against near-term earnings expansion potential. The company’s gross profit margin has maintained a level of 66% throughout the trailing twelve months.
Wall Street Weighs In Before Results
Bernstein reaffirmed its Outperform designation and indicated Oracle may be nearing the conclusion of its capital-raising requirements. This would represent a significant transition for an organization that has relied extensively on borrowing to support its AI infrastructure objectives. Bernstein also observed that Oracle has the potential to emerge as the third-largest hyperscaler.
Jefferies maintained its Buy recommendation while reducing its price objective to $290 from $320. The firm identified 115% OCI revenue growth and a 41% operating margin as the critical metrics to monitor.
Mizuho similarly reaffirmed an Outperform rating with a $320 target, highlighting an enhanced agreement with the Department of Veterans Affairs. The contract’s maximum value increased by approximately $17 billion and may continue through May 2031.
September 10 Earnings Preview
Options market activity suggests a possible 10% price swing in either direction when Oracle unveils its Q1 fiscal 2027 performance on September 10, following the market close.
Broader equity markets are providing minimal support today. The S&P 500 has declined 0.1% while the Nasdaq trades marginally higher. Oracle’s movement appears driven by company-specific developments.
Execution challenges and constrained free cash flow throughout the forecast horizon represent the primary concerns Morgan Stanley highlighted in justifying its Equalweight rating despite the increased price target.
Jefferies is monitoring OCI expansion and margin trends as the most transparent indicators of whether Oracle’s AI data center capital deployment is producing tangible outcomes.
The Veterans Affairs contract enhancement, which Mizuho emphasized this week, incorporates optional extensions that could prolong the arrangement through May 2031, providing Oracle with a durable government revenue stream.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
